Exponentially growing cells were seeded into 96-well plates and preincubated for
24 h. Then the medium was replaced with the fresh RPMI 1640 medium containing 0.01 to 50 μg/mL of gemcitabine or GEM-ANPs or ANPs. Samples were sterilized by 60 Co radiations before exposure to cells. Cell activity after 72 h of further culture was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay (MTT) with optical density at 490 nm (OD490 nm) using a micro plate reader (EL×800, BioTek, Winooski, VT, USA) (n = 5). A blank control group without medication was used as control. The inhibition rate was calculated as follows: where ODc and ODt are the OD490 nm values of the control group and the treatment group, respectively. The half maximal inhibitory concentration (IC50) was calculated with the Bliss method [16, 17]. Cell cycle analysis by flow cytometry After exposure to different samples for 72 h, Selleckchem GSK690693 PANC-1 cells were check details released by treatment with trypsin, washed with phosphate buffered solution (0.01 M, pH 7.4), and fixed in ice-cold 95% ethanol. After centrifugation at 252×g for 5 min, the cells were pretreated
with 1 mL Triton X-100 and centrifuged at 252×g for 5 min. A further treatment Milciclib manufacturer with 1 mL RNase was performed at 37°C for 10 min. Then the DNA of cells was stained with 1 mL propidium iodide. Cell cycle variation after different treatment was analyzed with a FACS flow cytometer (FACS Calibur, Becton-Dickinson, Franklin Lakes, NJ, USA) using the Cell Quest software. All experiments were performed in triplicate. Drug distribution and toxic side effect assessment in vivo Animals Male Sprague–Dawley (SD) rats, 4 to 5 weeks old, (Shanghai SLAC Laboratory Animal Co., Ltd., Shanghai, China) were housed in sterilized cages and fed with autoclaved food and water ad libitum. Athymic nude male mice, 6 to 8 weeks old, were purchased from Shanghai SLAC Laboratory Animal Co., Ltd. and housed in a specific pathogen-free animal facility. All animal procedures were approved by the institutional animal care committee, the Science and Technology Commission of Shanghai Municipality.
All guidelines met the ethical standards required by law and also complied with the guidelines for the use of experimental animals in China. Drug distribution Farnesyltransferase A total of 30 clean laboratory SD rats, with an average weight of 200 g, were randomly divided into three groups as follows: Group A: 110-nm GEM-ANPs Group B: 406-nm GEM-ANPs Group C: pure gemcitabine Samples were sterilized by 60 Co radiations and dispersed into 1 mL saline before injection. After being anesthetized with 10% chloral hydrate by intraperitoneal injection (3.0 mL/kg), SD rats were injected with the solution through the femoral vein. The amount of the injection in the 110-nm GEM-ANP group, 406-nm GEM-ANP group, and gemcitabine group was converted from gemcitabine (90 mg/kg, n = 10).